[{"Assets_0_Q3_USD":142916000.0,"CommonStockSharesOutstanding_0_Q3_shares":22734333.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-31683000.0,"NetIncomeLoss_1_Q3_USD":-7732000.0,"NetIncomeLoss_3_Q3_USD":-24740000.0,"StockholdersEquity_0_Q3_USD":83642000.0,"Ticker":"MRSN","CIK":"1442836","name":"MERSANA THERAPEUTICS, INC.","OfficialName":"Mersana Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"345233797.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171113"}]